2023
Bengaluru (India)
Series B
Scimplify is a science-first company specializing in the end-to-end sourcing and manufacturing of specialty chemicals. Founded in mid-2023 by Salil Srivastava, Sachin Santhosh, and Dheeraj Dhingra, the company is headquartered in Bengaluru, Karnataka, India. It operates within the chemical manufacturing industry, serving key markets globally, including the United States, Europe, Japan, and over 16 other countries.
Scimplify offers a comprehensive platform that integrates contract research, custom synthesis, route scouting, and commercial-scale chemical manufacturing. Its services cater to various industries such as pharmaceuticals, agrochemicals, industrial chemicals, flavors and fragrances, and personal care. The company's unique value proposition lies in its ability to provide a "plug-and-play" model, connecting businesses with a network of over 200 specialized manufacturing plants. This approach allows clients to access cost-efficient production without the need for dedicated facilities.
Scimplify generates revenue primarily through its B2B platform, which connects global buyers with specialized manufacturing partners. The company's revenue streams likely include:
Commission-based Sales: Scimplify earns commissions on transactions facilitated through its platform.
Service Fees: It charges fees for R&D services, custom synthesis, and route scouting.
Platform Subscription: Businesses may pay for access to its proprietary platform, ATOMS, which offers real-time visibility and regulatory compliance.
Scimplify primarily targets:
B2B Clients: Pharmaceutical companies, agrochemical manufacturers, industrial chemical producers, and businesses in the flavors and fragrances sector.
Enterprise Clients: Large corporations seeking end-to-end chemical manufacturing solutions.
The company's growth strategy focuses on:
Global Market Expansion: Expanding exports beyond the current 16 countries and strengthening its presence in key industries.
Product Innovation: Enhancing its R&D capabilities to address complex chemical challenges.
Strategic Partnerships: Collaborating with leading innovators and manufacturers to expand its network.
Platform Development: Continuously improving its ATOMS platform for better customer experience and operational efficiency.
Scimplify stands out from competitors due to its:
Full-stack Solution: Combining scientific expertise with a vast network of manufacturing plants.
Flexibility and Speed: Ability to rapidly pivot across different chemical processes and scale production based on real-time customer needs.
Innovative R&D Capabilities: Providing expertise typically inaccessible to individual manufacturers.
Unlike traditional manufacturers, Scimplify's model allows for adaptability and responsiveness to market needs, making it a preferred choice for businesses seeking agile and cost-effective chemical manufacturing solutions.
Scimplify is revolutionizing the specialty chemical industry with its innovative, R&D-led manufacturing approach. By offering a seamless integration of scientific expertise and manufacturing capabilities, the company is poised to continue its rapid growth and expansion into new markets. For investors, researchers, and industry professionals, Scimplify represents a forward-thinking company that is transforming the way specialty chemicals are developed, manufactured, and distributed globally.
$54.2Million
3
$40.0 Million, Series B
as of March 12, 2025
$150Million
as of March 12, 2025
-
as of N/A
3one4 Capital
and 4 more155
N/A
-
Date | Round Name | Amount | Valuation | Revenue | Revenue Multiple | Investors |
---|---|---|---|---|---|---|
March 12, 2025 | Series B | $40.0 Million | $150 Million | - | - | Accel, Bertelsmann India Investments, Omnivore, 3one4 Capital, Universal Materials Incubator, Beenext |
August 9, 2024 | Series A | $10.4Million | $78.7Million | - | - | Omnivore, 3one4 Capital, Bertelsmann India Investments, Beenext, Universal Materials Incubator |
December 7, 2023 | Seed | $3.8Million | $14.0Million | - | - | 3one4 Capital, Beenext, Real Time Accelerator Fund, Innoven Capital, Alteria Capital |